The european commission in Covid-19 vaccine cooperation: leadership vs coronationalism?

被引:10
|
作者
Deters, Henning [1 ]
Zardo, Federica [2 ]
机构
[1] Univ Vienna, EIF Ctr European Integrat Res, Dept Polit Sci, Vienna, Austria
[2] Danube Univ Krems, Dept Migrat & Globalisat, Krems, Austria
关键词
COVAX; COVID-19; European Commission; leadership; procurement; vaccines; EU;
D O I
10.1080/13501763.2022.2064900
中图分类号
D0 [政治学、政治理论];
学科分类号
0302 ; 030201 ;
摘要
During the first weeks of the Covid-19 pandemic, European Union (EU) member states competed over scarce countermeasures. Regarding vaccines, a few member states launched exclusive joint endeavours, yet eventually, the EU centralised vaccine provisioning. The EU's external vaccine diplomacy proceeded almost inversely. After stepping into the breach in global health governance, European leadership faltered and global collaboration progressed more slowly. This article explores Europe's diverging trajectories in the regional and global provisioning of Covid-19 vaccines. Focussing on the European Commission's leadership, we investigate to what extent it promoted regional and international cooperation and with what success. We also explain which factors enabled and constrained Commission leadership. Employing a controlled comparison and process tracing, we find that Commission leadership was more extensive and impactful in regional than in global vaccine provisioning. Member state support was the main enabling condition. Without support, institutional capacity and resources were insufficient for impactful leadership.
引用
收藏
页码:1051 / 1071
页数:21
相关论文
共 50 条
  • [41] COVID-19 vaccine hesitancy
    Eve Dubé
    Noni E. MacDonald
    [J]. Nature Reviews Nephrology, 2022, 18 : 409 - 410
  • [42] Mucosal COVID-19 vaccine
    Devi, Sharmila
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 776 - 776
  • [43] Vaccine against COVID-19
    Picazo, Juan J.
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (06) : 569 - 598
  • [44] COVID-19 Vaccine Hesitancy
    Storey, Doug
    [J]. GLOBAL HEALTH-SCIENCE AND PRACTICE, 2022, 10 (01):
  • [45] COVID-19 Vaccine and Myocarditis
    Salah, Husam M.
    Mehta, Jawahar L.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 157 : 146 - 148
  • [46] COVID-19 vaccine safety
    Kostoff, Ronald N.
    Briggs, Michael B.
    Porter, Alan L.
    Spandidos, Demetrios A.
    Tsatsakis, Aristidis
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (05) : 1599 - 1602
  • [47] Access to the COVID-19 Vaccine
    Zavras, Dimitris
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (17)
  • [48] A new COVID-19 vaccine?
    Devi, Sharmila
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 35 - 35
  • [49] Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
    Omer, Saad B.
    Benjamin, Regina M.
    Brewer, Noel T.
    Buttenheim, Alison M.
    Callaghan, Timothy
    Caplan, Arthur
    Carpiano, Richard M.
    Clinton, Chelsea
    DiResta, Renee
    Elharake, Jad A.
    Flowers, Lisa C.
    Galvani, Alison P.
    Lakshmanan, Rekha
    Maldonado, Yvonne A.
    McFadden, SarahAnn M.
    Mello, Michelle M.
    Opel, Douglas J.
    Reiss, Dorit R.
    Salmon, Daniel A.
    Schwartz, Jason L.
    Sharfstein, Joshua M.
    Hotez, Peter J.
    [J]. LANCET, 2021, 398 (10317): : 2186 - 2192
  • [50] Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?
    Petersen, Michael Bang
    Jorgensen, Frederik
    Lindholt, Marie Fly
    [J]. VACCINE, 2022, 40 (04) : 558 - 561